Clinical Trials Logo

Tolerance clinical trials

View clinical trials related to Tolerance.

Filter by:

NCT ID: NCT06442293 Not yet recruiting - Safety Issues Clinical Trials

Safety and Tolerability of 2 Dietary Supplement Beverages Designed to Maintain Healthy Blood Pressure.

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

This study is designed to evaluate the safety and tolerability of two distinct dietary supplement beverage formulations designed to maintain normal blood pressure. In this study, safety and tolerability will be assessed among otherwise healthy, normotensive individuals.

NCT ID: NCT06286488 Active, not recruiting - Obesity Clinical Trials

Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza

Start date: September 15, 2020
Phase: Phase 4
Study type: Interventional

The aim of the study is to evaluate simultaneously the immunological and clinical efficacy and tolerability of an influenza vaccine, inactivated, quadrivalent, with cleaved virus, in patients at risk for severe and complicated influenza routinely vaccinated against influenza in family medicine clinics or specialty clinics (pediatric, internal medicine, cardiology, gynecological diabetes, pregnant women, transplant).

NCT ID: NCT06232460 Not yet recruiting - Tolerance Clinical Trials

An Open Label, Dose-escalation Study, Assessing the Safety and Tolerability of a Collagen Peptide

Start date: January 29, 2024
Phase: N/A
Study type: Interventional

This study evaluates the safety and tolerability of three different doses (5 g, 10 g and 20 g) of a collagen powder in healthy adults over a 12-week period.

NCT ID: NCT06189170 Not yet recruiting - Safety Issues Clinical Trials

Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients

Start date: June 10, 2024
Phase: Early Phase 1
Study type: Interventional

This study will explore the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of KP405 as a potential new treatment for Parkinson's disease.

NCT ID: NCT06187233 Completed - Clinical trials for Patient Satisfaction

The Effects of Binaural Beats on Pain, Anxiety, and Procedure Tolerance in Patients Undergoing Colonoscopy Without Sedation

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study was to investigate the effect of binaural beats on anxiety, pain and tolerance during colonoscopy without sedation

NCT ID: NCT06141096 Recruiting - Safety Issues Clinical Trials

MB07133 for the Treatment of Patients With Unresectable Hepatocellular Carcinoma

MB07133
Start date: January 17, 2020
Phase: Phase 2
Study type: Interventional

A randomized, open, multicenter clinical trial design was adopted, planned to be conducted in three stages, with 91 participants expected to be included in the study to evaluate the efficacy, tolerance, and safety of different doses of MB07133 in the treatment of unresectable advanced primary liver cancer.

NCT ID: NCT06114524 Completed - Clinical trials for Patient Satisfaction

Effect of Binaural Beats on Level of Anxiety and Toleration in Patients Undergoing Upper Gastrointestinal Endoscopy Without Sedation

Start date: September 15, 2023
Phase: N/A
Study type: Interventional

To investigate the anxiolytic effects of binaural beat-embedded audio in patients undergoing sedation-free upper gastrointestinal endoscopy

NCT ID: NCT06034951 Completed - Tolerance Clinical Trials

Acceptability and Tolerance Study of a High Energy Tube Feed With Food Derived Ingredients

Start date: May 24, 2023
Phase: N/A
Study type: Interventional

Enterally fed adults and children who are assessed by the dietitian as requiring an adult high-energy, fibre-containing enteral formula will be recruited. Data from 15 participants are required in order to submit an application to the Advisory Committee on Borderline Substances (ACBS) for product registration.

NCT ID: NCT05978908 Recruiting - Safety Issues Clinical Trials

Phase1 First in Human Ascending Dose Study to Evaluate the Safety and Tolerability of FC-12738 in Health Adults

Start date: February 20, 2024
Phase: Phase 1
Study type: Interventional

A Phase I, Randomized, Double-Blind, Placebo-Controlled, First-in-human, Single-Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of retro enversio (RT) thymopentin in Healthy Adult Participants and Patients with Amyotrophic Lateral Sclerosis (ALS)

NCT ID: NCT05960045 Not yet recruiting - Tolerance Clinical Trials

Testing Tolerance in Cow Milk Protein Allergy Patients: Milk Ladder or Direct Milk Administration?

Start date: August 20, 2023
Phase: N/A
Study type: Interventional

Majority of children outgrow their allergies, however there are two different methods to re-introduce milk products in the infant diet either direct milk intake in escalating doses or milk ladder, starting with baked milk products instead of pure milk. This study aims to compare rate of tolerance after milk reintroduction among patient with cow milk protein allergy (CMPA) diagnosed by elimination re-challenge test after six months of elimination diet by milk ladder versus direct milk intake.